Resources

Displaying 193 - 204 of 629 Resources

Keyword

Resource Category

Discipline

Diabetes

Endocrinology

Clinical Area

Endocrinology Category

Listing Status

- Any -

Current

Archived

Impact of Semaglutide on Body Composition in Adults with Overweight or Obesity: Exploratory Analysis of the STEP 1 Study

Resource Type

Clinical Area

Obesity Treatments for diabetes Type 2 diabetes mellitus

Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for patients with type 1 diabetes

Resource Type

Clinical Area

Treatments for diabetes Type 1 diabetes mellitus

Introducing a local HHS protocol at the beginning of the COVID-19 pandemic: a review of HHS management against national standards before and after

Resource Type

Clinical Area

COVID-19 Inpatient care

Use of a simplified local guideline to optimise “front door” management of diabetes and hyperglycaemia in patients with COVID-19

Resource Type

Clinical Area

COVID-19 Diabetic hyperglycaemia

Hyperglycaemic emergencies during the COVID-19 pandemic in East London, one of the worse affected areas in the UK

Resource Type

Clinical Area

COVID-19 Diabetic hyperglycaemia Inpatient care

Cortisol measurement post steroids (Dexamethasone) treatment for COVID-19

Resource Type

Clinical Area

COVID-19 Inpatient care

One-third of diabetes patients with hyperkalaemia during acute admission have reninaldosterone angiotensin system (RAAS) antagonists discontinued by hospital discharge

Resource Type

Clinical Area

The absence of diabetic autoantibodies when routinely tested in adult-onset type 1 diabetes is associated with a high prevalence of treatment change & successful insulin cessation

Resource Type

Clinical Area

Type 1 diabetes mellitus

Glycaemic outcomes associated with do-it-yourself artificial pancreas systems (DIYAPS): Initial insights from the Association of British Clinical Diabetologists (ABCD) DIYAPS audit programme

Resource Type

Clinical Area

Diabetes technology Pumps and pump technology

The impact of empagliflozin dose on HbA1c & weight outcomes at 6 & 12 months: updated analysis from the ABCD empagliflozin audit programme

Resource Type

Clinical Area

Treatments for diabetes Type 2 diabetes mellitus

Management of hyperglycaemia in patients treated with Dexamethasone for COVID-19

Resource Type

Clinical Area

COVID-19 Hypoglycaemia Inpatient care Treatments for diabetes

Once-Weekly Semaglutide 2.4 mg Improved Glucose Metabolism and Prediabetes in Adults with Overweight/Obesity in the STEP 1 Trial

Resource Type

Clinical Area

Type 2 diabetes mellitus